Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress
Pan-ACT
Pandemic Acceptance and Commitment Therapy (Pan-ACT): Feasibility and Acceptability of Telehealth Delivery With Older Veterans
2 other identifiers
observational
24
1 country
1
Brief Summary
Older adults have been disproportionately impacted and distressed by the COVID-19 pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These fears and avoidant behaviors will have lasting effects if not treated with effective, safe, and convenient psychological interventions. This study will evaluate the acceptability and feasibility of delivering a small group intervention, called Acceptance and Commitment Therapy (ACT), through a telehealth modality to Veterans ages 65 and older who are experiencing pandemic-related emotional and physical distress. ACT helps decrease emotional suffering, improve well-being and promote positive behavior change by increasing one's psychological flexibility through the practice of mindfulness, acceptance, and values-based behaviors. The knowledge gained from this study will be used to better tailor the invention to meet the needs of older Veterans in an era of post-pandemic recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2022
CompletedFirst Submitted
Initial submission to the registry
June 21, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2025
CompletedJanuary 27, 2025
January 1, 2025
2.5 years
June 21, 2022
January 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of study protocol - retention
Rate of study completion
Through study completion, approximately 2 years
Feasibility of study protocol - telehealth
Percent of participants who have telehealth capability for duration of intervention
Through study completion, approximately 2 years
Acceptability of intervention - group attendance
Percent of participants who attend 70% or more of intervention sessions
Through study completion, approximately 2 years
Other Outcomes (5)
Acceptability of study protocol - enrollment
Throughout active enrollment period, approximately 1.5 years
Acceptability of study protocol - assessment completion
Through study completion, approximately 2 years
Feasibility of study protocol - timeline
Through study completion, approximately 2 years
- +2 more other outcomes
Study Arms (1)
Veterans
Veterans will be ages 65 and older, cognitively intact, and experiencing pandemic-related stress.
Interventions
Pan-ACT is a 10-session, closed group, transdiagnostic intervention for older adults.
Eligibility Criteria
Veterans ages 50 and older receiving services at the Tuscaloosa VA Medical Center (TVAMC) will be recruited from primary care, home-based primary care, and mental health clinics.
You may qualify if:
- Veteran
- receives care at Tuscaloosa VA Medical Center
- score of 9 or greater on the COVID-19 Mental Health Impacts Scale
- English speaking
- provides written informed consent
You may not qualify if:
- diagnosis of dementia
- score of 31 or less on the Modified Telephone Interview for Cognitive Status
- actively suicidal or homicidal
- actively psychotic
- unstable medical condition
- active substance use disorder
- currently participating in another CBT-based intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Tuscaloosa, Alabama, 35404-5015, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lori Lynne Davis, MD AB
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2022
First Posted
June 27, 2022
Study Start
June 15, 2022
Primary Completion
December 31, 2024
Study Completion
January 23, 2025
Last Updated
January 27, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Data sets will have no identifying information of participants (participants ages above 89 will be coded as "90 or above" in accordance with HIPAA regulations). In addition, no Clinical Site identifiers beyond the code numbers will be included in the data set. A "dictionary" dataset will also be included which will include description labels for all the variables. The archives will also include the data collection forms and data collection instructions, including coding schemes and scoring algorithms, and study manuals. These documents will be archived as Adobe Acrobat (.pdf) files. No audio files, video files, or qualitative transcripts will be shared.